Axsome Therapeutics (AXSM) total assets

Total assets · fiscal 2025
$689.81M

Axsome Therapeutics (AXSM) had total assets of $689.81M at the end of fiscal 2025 (December 31, 2025). That is 21.3% higher than the $568.50M of fiscal 2024. Figures as of 18 Nov 2026, 01:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$689.81M
Change on fiscal 2024
+21.3%
Growth, 5 years
+30.0% a year
Growth, 10 years
+30.3% a year
Highest on record
$689.81Mfiscal 2025
Lowest on record
$15.38Mfiscal 2018
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Axsome Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 30.0% a year; over ten years the rate was 30.3% a year. Across the 11 fiscal years on record (2015–2025), the highest was $689.81M in fiscal 2025 and the lowest $15.38M in fiscal 2018.

History · 11 fiscal years

Total assets by fiscal year

Axsome Therapeutics total assets, year by year

Axsome Therapeutics (AXSM) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$689.81M 21.3% up
2024$568.50M 3.4% down
2023$588.24M 77.5% up
2022$331.48M 277.6% up
2021$87.79M 52.8% down
2020$186.13M 15.6% down
2019$220.55M 1,334.1% up
2018$15.38M 56.7% down
2017$35.56M 7.0% down
2016$38.21M 22.1% down
2015$49.08M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Axsome Therapeutics and comparable companies
CompanyTotal assetsFiscal year
Immunovant IMVT$957.01M2026
Axsome Therapeutics AXSM$689.81M2025
Chemed CHE$1.54B2025
Oruka Therapeutics ORKA$488.62M2025
Arrowhead Pharmaceuticals ARWR$1.74B2026
MSA Safety MSA$2.55B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AXSM

Axsome Therapeutics, figure by figure

Axsome Therapeutics (AXSM) overview: price, valuation and scorecardAll health care companies by market value

Axsome Therapeutics total assets: questions and answers

How large are Axsome Therapeutics's total assets?

Axsome Therapeutics (AXSM) had total assets of $689.81M at the end of fiscal 2025 (December 31, 2025). That is 21.3% higher than the $568.50M of fiscal 2024.

What is the growth rate of Axsome Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 30.0% a year; over ten years the rate was 30.3% a year.

What are the highest and lowest total assets figures on record for Axsome Therapeutics?

Across the 11 fiscal years on record (2015–2025), the highest was $689.81M in fiscal 2025 and the lowest $15.38M in fiscal 2018.

How is Axsome Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Axsome Therapeutics (AXSM) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/AXSM/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.